Work

344MO ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases

Year: 2024

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.292

Authors: F. Ma, F. Qiu, Z. Tong, J. Wang, Y. Shi, L. Li, G. Yu, H. Shi, X. Wu, A. Liu, Y. Zhang, H. Wang, Y. Cheng, H. Yang, H. Li, J. Chang, Q. Zhou

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Second Affiliated Hospital of Zhejiang University, Zhejiang University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Weifang People's Hospital, First Affiliated Hospital of Gannan Medical University, Hubei Cancer Hospital, Second Affiliated Hospital of Nanchang University, Beijing Hospital, Nanchang Medical College, Jilin Province Tumor Hospital, Affiliated Hospital of Hebei University, Peking University Cancer Hospital, Affiliated Hospital of Guizhou Medical University

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402561709

FWCI: 0.254

Cites:

Cited by: 1

Related to: 10